tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Zai Lab (ZLAB)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCA Healthcare (HCAResearch Report) and Zai Lab (ZLABResearch Report) with bullish sentiments.

HCA Healthcare (HCA)

Jefferies analyst Brian Tanquilut reiterated a Buy rating on HCA Healthcare today and set a price target of $275.00. The company’s shares closed last Friday at $202.03.

According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 5.8% and a 54.7% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Privia Health Group, and Quest Diagnostics.

HCA Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $226.33, representing a 7.8% upside. In a report issued on July 11, Raymond James also maintained a Buy rating on the stock with a $220.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Zai Lab (ZLAB)

In a report issued on July 22, Michael Yee from Jefferies maintained a Buy rating on Zai Lab, with a price target of $80.00. The company’s shares closed last Friday at $43.87, close to its 52-week low of $22.51.

According to TipRanks.com, Yee is a 1-star analyst with an average return of -2.6% and a 40.8% success rate. Yee covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, LianBio Sponsored ADR, and Olema Pharmaceuticals.

Currently, the analyst consensus on Zai Lab is a Strong Buy with an average price target of $136.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on HCA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More